Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ramsay Generale denteFRA:GD6 71 Days Sales Outstanding is 31.23 as of Jun. 2026, which is 3% below its 10-year median of 32.23. GuruFocus rates FRA:GD6 with a GF Score™ of 71/100 and a GF Value™ of €11.89. The stock has 6 warning signs investors should review. Among 664 Healthcare Providers & Services companies, Ramsay Generale dente ranks worse than 68.67% on this metric.
The historical rank and industry rank for Ramsay Generale dente's Days Sales Outstanding or its related term are showing as below:
FRA:GD6'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 25.72 Med: 32.23 Max: 64.63
Current: 64.63
During the past 13 years, Ramsay Generale dente's highest Days Sales Outstanding was 64.63. The lowest was 25.72. And the median was 32.23.
FRA:GD6's Days Sales Outstanding is ranked worse than 68.67% of 664
companies
in the Healthcare Providers & Services industry
Industry Median: 45.78
vs FRA:GD6: 64.63
Ramsay Generale dente's Days Sales Outstanding
declined
from Jun. 2025 (35.35) to Jun. 2026 (31.23).
Ramsay Generale dente (FRA:GD6) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Ramsay Generale dente Days Sales Outstanding Related Terms
Ramsay Generale dente Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Ramsay Generale dente's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ramsay Generale dente Days Sales Outstanding Chart
FRA:GD6 vs HCA, THC, EHC: Days Sales Outstanding Comparison
For the Medical Care Facilities subindustry, Ramsay Generale dente's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ramsay Generale dente Days Sales Outstanding vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ramsay Generale dente's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Ramsay Generale dente's Days Sales Outstanding falls into.
Ramsay Generale dente Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ramsay Generale dente (FRA:GD6) has a Days Sales Outstanding of 31.23 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Ramsay Generale dente and its competitors. This is near median its historical median of 32.23. Over the past decade, Ramsay Generale dente's Days Sales Outstanding has ranged from 25.72 to 64.63. According to the industry distribution chart, Ramsay Generale dente ranks #456 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 68.7%.
Is Ramsay Generale dente's Days Sales Outstanding too high?
Ramsay Generale dente's current Days Sales Outstanding of 31.23 is near median its 10-year median of 32.23. Over the past 10 years, this metric has ranged from a low of 25.72 to a high of 64.63. The Healthcare Providers & Services industry median Days Sales Outstanding is 45.78. Ramsay Generale dente's value of 31.23 is 31.8% below this industry median. Based on the distribution chart, Ramsay Generale dente ranks #456 out of 664 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Ramsay Generale dente has a GF Score™ of 71/100, reflecting its overall financial health beyond just this single metric.
How does Ramsay Generale dente's Days Sales Outstanding compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Ramsay Generale dente ranks #456 out of 664 companies for Days Sales Outstanding. This places Ramsay Generale dente in the lower half of its industry. The industry median Days Sales Outstanding is 45.78. Ramsay Generale dente's value of 31.23 is 31.8% below this benchmark. Historically, Ramsay Generale dente's own Days Sales Outstanding has ranged from 25.72 to 64.63 over the past decade. While the company's 10-year median is 32.23 vs. the industry median of 45.78, Ramsay Generale dente has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Healthcare Providers & Services company?
The median Days Sales Outstanding among Healthcare Providers & Services companies is 45.78, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ramsay Generale dente's current Days Sales Outstanding of 31.23 is 31.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Ramsay Generale dente and its competitors. For the Healthcare Providers & Services industry, the median Days Sales Outstanding is 45.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ramsay Generale dente's current Days Sales Outstanding is 31.23, which is near median its own 10-year median of 32.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ramsay Generale dente stock overvalued right now?
Ramsay Generale dente (FRA:GD6) has a current Days Sales Outstanding of 31.23. The stock's GF Value™ is €11.89, compared to a current price of €10.85 — trading 8.7% below its estimated fair value. The current Days Sales Outstanding is 31.23, which is near median its 10-year median of 32.23 and 31.8% below the Healthcare Providers & Services industry median of 45.78. Ramsay Generale dente's overall GF Score™ is 71/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Ramsay Generale dente (FRA:GD6), the current Days Sales Outstanding is 31.23 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ramsay Generale dente (FRA:GD6) Overvalued in 2026?
Based on GuruFocus' analysis, Ramsay Generale dente stock appears to be undervalued.
The current stock price of €10.85 is trading 8.7% below its estimated GF Value™ of €11.89.
Key valuation signals for FRA:GD6:
Days Sales Outstanding: 31.23 (near median its 10-year median of 32.23)
GF Value™: €11.89 vs. price of €10.85 (8.7% below fair value)
Industry Position: 31.8% below the Healthcare Providers & Services median (#456 of 664)
No single metric tells the full story. See the FRA:GD6 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ramsay Generale de Sante SA operates in the private healthcare sector in France. The company provides a comprehensive range of patient care services in thirteen business segments: Nouvelle Aquitaine, Bourgogne-Franche Comte, Brittany, Centre-Val de Loire, Hauts de France, Normandy, Provence Alpes Cote d'Azur, Ile de France, Auvergne-Rhone Alpes, Occitanie, Italy, Nordics, and Head Office. It generates maximum revenue from the Ile de France segment. The company also specializes in cardiology, heart surgery, digestive surgery, dermatology, urology, ophthalmology, vascular and endovascular surgery.
71GF Score
Get the complete analysis for FRA:GD6
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:GD6 has been successfully added to your 
